IBD Summit: From Rapid-Fire Insights to Real-World Cases

2.00CME

2.00AAPA

2.00ABIM MOC

120MINS

Overview

Provider Statement

This continuing education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by educational grants from AbbVie Inc.; Genentech, a member of the Roche Group; Johnson & Johnson; Merck & Co., Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Activity Description

Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, remains a complex and evolving condition that requires personalized, evidence-based care. In this educational program, faculty examine the current treatment landscape, with a focus on applying evidence-based strategies to select and sequence advanced therapies. In the Rapid-Fire Review: Hot Topics in IBD session, expert faculty spotlight emerging treatment options and how they may help to optimize patient outcomes. The program also features the IBD Situation Room, a discussion-based forum where faculty analyze real-world clinical cases and debate best practices. Through these dynamic sessions, participants will strengthen their ability to provide individualized, goal-directed care in clinical practice.

Target Audience

The intended audience for this activity is US-based gastroenterologists, internists, and advanced practice providers involved in the management of patients with IBD.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Apply the latest clinical evidence to position advanced therapies for the management of patients with moderate-to-severe IBD.
Individualize clinical decision-making based on patient-centered goals and treatment targets.
Review the evidence for emerging treatment options for IBD.

Activity Co-Chairs

David T. Rubin, MD
Joseph B. Kirsner Professor of Medicine
Chief, Section of Gastroenterology, Hepatology and Nutrition
Director, Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL

Corey A. Siegel, MD, MS
Constantine and Joyce Hampers Professor of Medicine
Geisel School of Medicine at Dartmouth
Director, Center for Digestive Health
Dartmouth-Hitchcock Medical Center
Lebanon, NH

Faculty

Adam S. Cheifetz, MD, AGAF, FACG
Director, Center for Inflammatory Bowel Disease
Medical Director, Infusion Services
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Boston, MA

Jill K. J. Gaidos, MD, FACG, AGAF
Associate Professor
Vice Chief, Section of Gastroenterology
Medical Director, Inflammatory Bowel Disease Program
Yale University
New Haven, CT

Laura E. Raffals, MD, MS
Vice Chair, Department of Medicine
Professor of Medicine
Mayo Clinic
Rochester, MN

Elizabeth A. Spencer, MD, MS
Assistant Professor of Pediatric Gastroenterology
Associate Program Director, Pediatric Research Residency
Director, Pediatric IBD Translational Research Program
Co-Director, IBD Prevention Program
Icahn School of Medicine at Mount Sinai
New York, NY

Fellow Panelists

Jamie M. Horrigan, MD
2nd Year Gastroenterology Fellow
Geisel School of Medicine at Dartmouth
Dartmouth Hitchcock Medical Center
Lebanon, NH

Navneet Natt, MD, FRCPC
Advanced IBD Fellow
The University of Chicago Medicine
Chicago, IL

Patient Advocate

Jessica Caron, MS
Founder, www.Chronically-Jess.com
Goffstown, NH

Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, BS, PA-C

Accreditation

ACCME Jointly accredited In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

abim Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

aapa Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until November 25, 2026. PAs should only claim credit commensurate with the extent of their participation.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

This enduring material is approved for 1 year from the date of original release, November 26, 2025, to November 25, 2026.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of the 6 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or AAPA Category 1 CME credit certificate.

In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application. US Physicians who opt-in by providing their medical license number, state of licensure, and date of birth will have their credits automatically reported to the ACCME.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chairs and Faculty report the following relevant financial relationship(s)

Adam S. Cheifetz, MD, AGAF, FACG
Advisor: Aegirbio, Artizan, Prometheus
Consultant: AbbVie, Adiso, Biosynex, Celltrion, Fzata, Johnson & Johnson, Lilly
Speaker Contracted by Ineligible Company: AbbVie, BMS, Johnson & Johnson

Jill K. J. Gaidos, MD, FACG, AGAF
Consultant: Pfizer

Laura E. Raffals, MD, MS
Advisor: BMS, Janssen, Takeda
Consultant: Boomerang, Geneoscopy

David T. Rubin, MD
Consultant: AbbVie, Abivax, AltruBio, Athos, BMS, Celltrion, Connect Biopharma, Genentech, Iterative Health, Janssen, Johnson & Johnson, Lilly, Merck, Odyssey Thera, Pfizer, Sanofi, Spyre, Takeda, Vedanta Biosciences, Ventyx
Independent Research Contractor: Takeda

Corey A. Siegel, MD, MS
Consultant: AbbVie, Boomerang, Celltrion, Johnson & Johnson, Lilly, Napo, Path Healthcare, Pfizer, Prometheus, Sanofi, Takeda, Trellus Health
Speaker Contracted by Ineligible Company: AbbVie, Johnson & Johnson, Pfizer, Takeda
Independent Research Contractor: AbbVie, BMS, Celltrion, Johnson & Johnson, Lilly, Pfizer

Elizabeth A. Spencer, MD, MS
Advisor: Celltrion

Fellow Panelists report the following relevant financial relationship(s)

Jamie M. Horrigan, MD
No relevant financial relationships to disclose.

Navneet Natt, MD, FRCPC
No relevant financial relationships to disclose.

Patient Advocate reports the following relevant financial relationship(s)

Jessica Caron, MS
No relevant financial relationships to disclose.

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2025 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:

Specify the copyrighted work you believe has been infringed upon.
Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
Share your name, address, telephone number, and, if available, your email address.
Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614